Cite
HARVARD Citation
Moore, A. et al. (2021). Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?. Medicine. 100 (25), pp. e26388-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Moore, A. et al. (2021). Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?. Medicine. 100 (25), pp. e26388-. [Online].